These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21157531)

  • 1. Initial experience with an 11 MeV self-shielded medical cyclotron on operation and radiation safety.
    Pant GS; Senthamizhchelvan S
    J Med Phys; 2007 Jul; 32(3):118-23. PubMed ID: 21157531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical experience and challenges in the operation of medical cyclotron.
    Kumar R; Sonkawade RG; Pandey AK; Tripathi M; Damle NA; Kumar P; Bal CS
    Nucl Med Commun; 2017 Jan; 38(1):10-14. PubMed ID: 27755293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized
    M U Z; N F; S U M; M S; Kh K; G K
    J Biomed Phys Eng; 2019 Aug; 9(4):409-416. PubMed ID: 31531293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A "dose on demand" Biomarker Generator for automated production of [(18)F]F(-) and [(18)F]FDG.
    Awasthi V; Watson J; Gali H; Matlock G; McFarland A; Bailey J; Anzellotti A
    Appl Radiat Isot; 2014 Jul; 89():167-75. PubMed ID: 24650573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution of 2-deoxy-2[18F]-fluoro-D-glucose for metabolic imaging using positron emission tomography.
    Alagona P; Hart DT; Eikman EA
    Int J Card Imaging; 1994 Jun; 10(2):137-43. PubMed ID: 7963752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Futureproofing [
    Sowa AR; Jackson IM; Desmond TJ; Alicea J; Mufarreh AJ; Pham JM; Stauff J; Winton WP; Fawaz MV; Henderson BD; Hockley BG; Rogers VE; Koeppe RA; Scott PJH
    EJNMMI Radiopharm Chem; 2018 Dec; 3():12. PubMed ID: 30363401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation surveillance in and around cyclotron facility.
    Kaur A; Sharma S; Mittal B
    Indian J Nucl Med; 2012 Oct; 27(4):243-5. PubMed ID: 24019654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taking cyclotron
    Nelson BJB; Wilson J; Richter S; Duke MJM; Wuest M; Wuest F
    Nucl Med Biol; 2020; 80-81():24-31. PubMed ID: 32004935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The planning and design of a new PET radiochemistry facility.
    Jacobson MS; Hung JC; Mays TL; Mullan BP
    Mol Imaging Biol; 2002 Mar; 4(2):119-27. PubMed ID: 14537134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of
    Thakral P; Manda D; Das SS; Tandon P; Cb V; Malik D; Sen I
    Cancer Biother Radiopharm; 2023 Feb; 38(1):8-14. PubMed ID: 35763304
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioactive by-products of a self-shielded cyclotron and the liquid target system for F-18 routine production.
    Kambali I; Suryanto H; Parwanto
    Australas Phys Eng Sci Med; 2016 Jun; 39(2):403-12. PubMed ID: 26867652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting induced activity in the Havar foils of the (18)F production targets of a PET cyclotron and derived radiological risk.
    Martinez-Serrano JJ; Diez de Los Rios A
    Health Phys; 2014 Aug; 107(2):103-10. PubMed ID: 24978281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.
    Selivanova SV; Lavallée É; Senta H; Caouette L; Sader JA; van Lier EJ; Zyuzin A; van Lier JE; Guérin B; Turcotte É; Lecomte R
    J Nucl Med; 2015 Oct; 56(10):1600-8. PubMed ID: 26205300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of the PET bone agent (18)F-fluoride ion, simultaneously with (18)F-FDG by a single run of the medical cyclotron with minimal radiation exposure- a novel technique.
    Kumar R; Sonkawade RG; Tripathi M; Sharma P; Gupta P; Kumar P; Pandey AK; Bal C; Damle NA; Bandopadhayaya G
    Hell J Nucl Med; 2014; 17(2):106-10. PubMed ID: 25097896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of [
    Nkepang GN; Gali H; Houson H; Hedrick AF; Hayes B; Causey O; Inman P; Box J; Benton E; Galbraith W; Awasthi V
    Appl Radiat Isot; 2019 Aug; 150():19-24. PubMed ID: 31108335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutron measurements in the vicinity of a self-shielded PET cyclotron.
    Hertel NE; Shannon MP; Wang ZL; Valenzano MP; Mengesha W; Crowe RJ
    Radiat Prot Dosimetry; 2004; 108(3):255-61. PubMed ID: 15031447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of physical parameters during radiochemical synthesis of (18)F positron emission tomography radiopharmaceuticals.
    Tiwari AK; Varshney R; Kaushik A; Datta A; Singh L; Mishra AK
    Cancer Biother Radiopharm; 2011 Jun; 26(3):389-93. PubMed ID: 21711118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of a cyclotron in the production of positron emitting radionuclides].
    Martí-Climent J; Peñuelas I; Calvo R; Giménez M; Gámez C; Richter J
    Rev Esp Med Nucl; 1999 Aug; 18(4):261-7. PubMed ID: 10481107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers.
    Ishiwata K; Hayashi K; Sakai M; Kawauchi S; Hasegawa H; Toyohara J
    Ann Nucl Med; 2017 Jan; 31(1):84-92. PubMed ID: 27744544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.